Related Experiment Video

Updated: Aug 23, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression

Ruchi M Newman1, Arian Mobascher, Ursula Mangold

  • 1Program in Vascular Biology and Department of Surgery, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

The Journal of Biological Chemistry
|July 28, 2004
PubMed

Insights

Overproduction of ornithine decarboxylase (ODC) antizyme inhibits cell growth by degrading cyclin D1. This novel pathway bypasses traditional ubiquitination, offering new insights into cell cycle regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Overproduction of ornithine decarboxylase (ODC) antizyme is linked to cell growth inhibition.
  • The precise mechanism of antizyme-induced growth suppression is not fully understood but involves polyamine metabolism.
  • Antizyme targets ODC for degradation via the 26 S proteasome through a ubiquitin-independent mechanism.

Purpose of the Study:

  • To investigate the mechanism by which ODC antizyme induces cell growth inhibition.
  • To determine if antizyme affects other key regulatory proteins, specifically cyclin D1.
  • To elucidate the pathway of antizyme-mediated cyclin D1 degradation.

Main Methods:

  • In vitro assays to assess the interaction between antizyme and cyclin D1.
  • Proteasome degradation assays using purified 26 S proteasomes, antizyme, cyclin D1, and ATP.
  • In vivo studies involving antizyme up-regulation via spermine or overexpression.
  • Analysis of cyclin D1 levels in cells with altered antizyme expression.
  • Utilizing a cyclin D1 mutant (T286A) to assess pathway independence from ubiquitination.

Main Results:

  • Antizyme directly associates with cyclin D1, accelerating its degradation in vitro.
  • Antizyme up-regulation, induced by spermine or overexpression, reduces intracellular cyclin D1 levels.
  • Antizyme promotes cyclin D1 degradation via the proteasome independently of phosphorylation and ubiquitination.
  • Degradation of a T286A cyclin D1 mutant confirms the ubiquitin-independent nature of this pathway.

Conclusions:

  • Antizyme mediates the degradation of cyclin D1 through a novel, ubiquitin-independent proteasomal pathway.
  • This antizyme-driven cyclin D1 degradation likely contributes to the observed cell growth inhibition.
  • The findings reveal a new regulatory mechanism impacting cell cycle progression and polyamine metabolism.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.